• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN (IRVINE) PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN (IRVINE) PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Model Number FA-71500-35
Device Problem Migration or Expulsion of Device (1395)
Patient Problem Therapeutic Response, Decreased (2271)
Event Date 12/11/2015
Event Type  Injury  
Manufacturer Narrative
The pipeline device will not be returned for evaluation as it was implanted in the patient.The device was not returned; the reported event could not be confirmed.The cause of the event could not be conclusively determined from the reported information.Natarajan, s.K.Et al.(2016).The safety of pipeline flow diversion in fusiform vertebrobasilar aneurysms: a consecutive case series with longer-term follow-up from a single us center.Journal of neurosurgery, 125(1), 111-119.Doi:10.3171/2015.6.Jns1565 mdrs related to this article: 2029214-2016-00667 2029214-2016-00668 2029214-2016-00669 2029214-2016-00670 2029214-2016-00671 2029214-2016-00672.
 
Event Description
Medtronic received information from literature review that a patient underwent retreatment after pipeline implantation.The patient initially presented with headache.The patient was found to have a 17mm fusiform aneurysm in the posterior circulation.Three pipeline devices were implanted.There were no technical difficulties noted during the procedure.Seven-months post-procedure, follow-up angiogram showed foreshortening of a pipeline and aneurysm filling.It was not reported which of the three pipeline devices foreshortened.The patient underwent retreatment in which an additional pipeline device was implanted.At the latest angiographic follow up (15 months after the initial procedure), dsa showed no aneurysm remnant and patent pipeline.At the last clinical follow up (17 months after initial procedure), the patient mrs was 0.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PIPELINE EMBOLIZATION DEVICE
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer Contact
tricha miles
9775 toledo way
irvine, CA 92618
9496801224
MDR Report Key5852663
MDR Text Key51340476
Report Number2029214-2016-00669
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100018.S004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/12/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/07/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberFA-71500-35
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/12/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age36 YR
-
-